Clinical trial developed at Massey tests novel combination of chemotherapy and radiation therapy for the treatment of pancreatic cancer
A phase 1 clinical trial developed at VCU Massey Cancer Center is testing a combination of targeted therapy with standard chemotherapy and radiation given prior to surgery in patients with non-metastatic pancreatic cancer. Surgery is often the most effective treatment for pancreatic cancer, but in many cases it is not possible if the tumor has spread to other parts of the digestive system or nearby organs. Neoadjuvant therapy, or therapy prior to surgery, can help shrink tumors and make them operable.
Top Facebook stories of 2015
What were you most interested in seeing on our Facebook page last year? Here's a round-up of the top 10 most popular Facebook posts of 2015.
A righteous purpose
“We have a righteous purpose,” says Richard “Rick” Moran, Ph.D., a preeminent scientist at VCU Massey Cancer Center. “I ask my research students to walk through the oncology clinic every day to refresh their memories as to why we are here. The patient is the very real endpoint for research.”
Massey Cancer Center helps patient be father of the bride at bedside ceremony
Martin Lenhardt, Ph.D., was relegated to bed on Oct. 10, with little to no energy or chance of leaving the hospital in the near future, even for a day. Still, at Virginia Commonwealth University’s Massey Cancer Center, as he lay in bed surrounded by family and friends, he was allowed to play his rightful part as the proud father of the bride to his youngest daughter Megan Kinnison.
Twitter chat on genomics and precision medicine
Recently, the National Cancer Institute hosted a Twitter on “Genomics and Precision Medicine in Oncology.” VCU Massey Cancer Center medical oncologist Andrew Poklepovic, M.D., who is also a member of the Developmental Therapeutics research program at Massey and assistant professor in the Division of Hematology, Oncology and Palliative Care at the VCU School of Medicine, weighed in as the moderator posed a series of questions.